Cargando…

Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy

Interstitial pneumonia with autoimmune features is a complex and heterogeneous research classification without clear management and should be discussed on a case‐by‐case basis in a pluridisciplinary way. Rituximab could be used for severe lung involvement. The coronavirus crisis can hide other patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapuczinski, Abeline, Cotils, Michel, Gombeir, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133082/
https://www.ncbi.nlm.nih.gov/pubmed/34026182
http://dx.doi.org/10.1002/ccr3.4180
_version_ 1783695015948582912
author Kapuczinski, Abeline
Cotils, Michel
Gombeir, Yannick
author_facet Kapuczinski, Abeline
Cotils, Michel
Gombeir, Yannick
author_sort Kapuczinski, Abeline
collection PubMed
description Interstitial pneumonia with autoimmune features is a complex and heterogeneous research classification without clear management and should be discussed on a case‐by‐case basis in a pluridisciplinary way. Rituximab could be used for severe lung involvement. The coronavirus crisis can hide other pathologies in such a way that a diagnosis can be overlooked.
format Online
Article
Text
id pubmed-8133082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81330822021-05-21 Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy Kapuczinski, Abeline Cotils, Michel Gombeir, Yannick Clin Case Rep Case Reports Interstitial pneumonia with autoimmune features is a complex and heterogeneous research classification without clear management and should be discussed on a case‐by‐case basis in a pluridisciplinary way. Rituximab could be used for severe lung involvement. The coronavirus crisis can hide other pathologies in such a way that a diagnosis can be overlooked. John Wiley and Sons Inc. 2021-05-19 /pmc/articles/PMC8133082/ /pubmed/34026182 http://dx.doi.org/10.1002/ccr3.4180 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Kapuczinski, Abeline
Cotils, Michel
Gombeir, Yannick
Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title_full Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title_fullStr Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title_full_unstemmed Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title_short Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
title_sort successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133082/
https://www.ncbi.nlm.nih.gov/pubmed/34026182
http://dx.doi.org/10.1002/ccr3.4180
work_keys_str_mv AT kapuczinskiabeline successfultreatmentofinterstitialpneumoniawithautoimmunefeaturesusingrituximabassalvagetherapy
AT cotilsmichel successfultreatmentofinterstitialpneumoniawithautoimmunefeaturesusingrituximabassalvagetherapy
AT gombeiryannick successfultreatmentofinterstitialpneumoniawithautoimmunefeaturesusingrituximabassalvagetherapy